The application of cisplatin (1 mg/kg) significantly inhibited tumour growth (Figure 5A). When anti-IFNγ antibody was administered two days before the first injection of cisplatin, it did not affect the outcome of chemotherapy (Figure 5A). Here, IFNG is linked to neoplasm.